SOUTH CALGARY - Shared Care · Janssen Inc., Purdue Pharma, and Shire Canada. • Allan S. Kaplan has participated in advisory boards for Shire Canada. • Margaret Oakander has participated

SOUTH CALGARY

Pre-Conference SessionCalgary Zone Mental Health Day:2014 Mackid Symposium Follow-up

Thursday, June 18, 2015Sheraton Ballroom Sheraton Cavalier Hotel Calgary, Alberta

Learning ObjectivesAfter participating in the pre-conference workshop, attendees will be able to:

• Assess their understanding of key topics presented at the 2014 Mackid Symposium and revisit topics requiring further education

• Acquire updated information on the management of complex and common mental illness and addiction issues frequently seen in primary care practice

• Differentiate between common treatment options for patients at risk of suicide, as well as those with eating disorders, ADHD, depression, perinatal anxiety and other common patient concerns

AccreditationRoyal College of Physicians and Surgeons of AlbertaAs part of the 16th Annual Collaborative Mental Health Care Conference, the 2014 Mackid Symposium Follow-up Pre-Conference Workshop is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada, and approved by the University of Calgary Office of Continuing Medical Education and Professional Development.

Participants can claim up to a maximum of 6 study credits for attendance at this pre-conference workshop.

College of Family Physicians of CanadaThis program has been accredited by the College of Family Physicians of Canada and the Alberta Chapter for up to 19.25 Mainpro-M1 credits

Faculty DisclosuresThe following Faculty have disclosed a potential conflict of interest:

• Tim Ayas has participated in advisory boards for Janssen‐Ortho and Shire Canada, and has received grants or honoraria from Lundbeck Canada Inc. and Purdue Pharma.• Sara Binder has participated in advisory boards for Janssen Inc. and Shire Canada, and has received grants or honoraria from Janssen Inc., Purdue Pharma, and Shire Canada.• Allan S. Kaplan has participated in advisory boards for Shire Canada.• Margaret Oakander has participated in advisory boards or committees for Astra Zeneca, Biovail, GlaxoSmithKline, Janssen Inc., Lilly, Lundbeck Canada Inc., Otsuka Canada, Pfizer, Valeant and Wyeth, and has received grants or honoraria from Astra Zeneca, Biovail, Bristol-Myers Squibb Canada, Janssen Inc., Lundbeck Canada Inc., Lilly, Otsuka Canada, Pfizer, Shire Canada, Valeant and Wyeth. She has undertaken research for GlaxoSmithKline, Lilly, Lundbeck, Pfizer and Wyeth and has been involved with CME development for the Canadian Psychiatric Association and the University of Calgary.• David Tano has participated in advisory boards for Janssen Inc. and has received consulting fees from Janssen Inc.• Richard Ward has participated in advisory boards for Boehringer Ingelheim, Janssen Inc., Lundbeck Canada Inc., Pfizer, Sanofi Canada, and Shire Canada, and is a member of a speakers bureau or has received grants or honoraria from Astra Zeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb Canada, Janssen Inc., Lilly, Merck, Sanofi Canada and Shire Canada.

Conference Secretariat

Suite 307, 10328 81 AvenueEdmonton, Alberta T6E 1X2tel 780.436.0983 | fax [email protected] | www.buksa.com

Program Thursday, June 18, 2015

All sessions take place in the Sheraton Ballroom unless otherwise noted

* Special emphasis on prescribers ** Special emphasis on MDT

7:30 – 8:00 am Registration Opens Breakfast on Own

8:00 – 8:15 am Introduction and Overview Rick Ward, Alberta Health Services, Calgary Zone

8:15 – 9:15 am “Self Murder” Suicide: A Review of Facts, Risk Factors, and Assessments (Oh, and Homocide Too) David Tano, Department of Psychiatry, University of Calgary Following this presentation, attendees will be able to:

• Review basic facts regarding suicide • Identify the differences between “suicidality” and “parasuicidality” • Identify the risk factors for suicide

9:15 – 9:30 am Room Change

9:30 – 10:30 am Breakout Sessions 1

A: Treatment Resistant Depression* Sheraton Ballroom Margaret Oakander, Department of Psychiatry, University of Calgary

The session uses a case based approach to explore adjunctive treatment strategies for treatment resistant depression with the goal of maximizing chances of full functional recovery

Following this presentation, attendees will be able to:

• Assess the evidence to support completely treating depressive symptoms with the goal of full functional recovery • Integrate treatment strategies for patients with depression who respond incompletely to antidepressant monotherapy • Describe the mechanism by which atypical antipsychotics are useful adjunctive therapy for patients with major depressive disorder (MDD)

B: Adult ADHD McKnight East Sara Binder, Department of Psychiatry, University of Calgary

This session will focus on ADHD in the adult population. The prevalence and socioeconomic impact of undiagnosed and untreated ADHD will be reviewed. ADHD symptom clusters will be presented while contrasting ADHD symptom presentation in children as compared to in adults. Commonly used screening tools will be discussed. The common co-morbidities of ADHD in adults and tips for differentiating ADHD symptoms from mood, anxiety and personality disorders will be covered. The session will include first line pharmacologic treatments for ADHD along with psychosocial interventions.

Calgary Zone Mental Health Day: 2014 Mackid Symposium Follow-up 1


• Review the prevalence and impact of undiagnosed and untreated ADHD in Adults • Gain a clear understanding of ADHD symptom identification, diagnostic tools and common comorbidities • Review first line treatments for ADHD in Adults

C: Depression Basics ** Alberta North

Rick Ward, Alberta Health Services, Calgary Zone

This interactive session will follow a case study approach that will highlight how depression presents in primary care. It will examine management principles with special focus on overcoming barriers to management. The emphasis in this workshop will be to address the needs of the participants and practical tips for practice. Following this session, attendees will be able to

• Articulate the incidence and natural history of depression • Assess patients for depression using DSM 5 criteria • Apply treatment principles where appropriate for scope of practice • Identify and address barriers to managing depression

D: Concurrent Disorders: Addiction and Mental Health Alberta South for Family Physicians Tim Ayas, Claresholm Centre for Mental Health & Addictions

This session will provide a brief overview of concurrent disorders, including definitions, epidemiology, and treatment suggestions. Following this presentation, attendees will be able to:

• Determine the appropriate focus when deciding whether to manage substance abuse or treat the psychiatric comorbidity • Assess whether a mood disorder exists when substance abuse is a predominate feature of the presentation • Utilize tips on management based on class of addiction

10:30 – 11:00 am Nutrition Break

11:00 am –12:00 pm Breakout Sessions 2 – Morning Sessions Repeat

A: Treatment Resistant Depression* Sheraton Ballroom

Margaret Oakander, Department of Psychiatry, University of Calgary

B: Adult ADHD McKnight East Sara Binder, Department of Psychiatry, University of Calgary

C: Depression Basics** Alberta North

Rick Ward, Alberta Health Services, Calgary Zone


D: Concurrent Disorders: Addiction and Mental Health Alberta South

for Family Physicians Tim Ayas, Claresholm Centre for Mental Health & Addictions

12:00 – 1:00 pm Lunch

1:00 – 2:00 pm Overview of Eating Disorders: Diagnosis, Etiology and Treatment Allan S. Kaplan, Faculty of Medicine, University of Toronto; Campbell Family Mental Health Research Institute; Center for Addiction and Mental Health

This session will provide an overview of the recognized eating disorders anorexia nervosa, bulimia nervosa and binge eating disorder. It will focus on the recently published DSM 5 diagnostic criteria for these disorders as well as our current understanding of the multi-determined etiology of these conditions. Finally, this session will review the evidences based treatments for these conditions.


• Understand the diagnostic differences between anorexia nervosa, bulimia nervosa and binge eating disorder • Articulate the environmental and neurobiological factors that may contribute to the risk for the development of eating disorders • Expand their knowledge base about the evidence based treatments currently available for anorexia nervosa, bulimia nervosa and binge eating disorder

2:00 – 2:15 pm Room Change

2:15 – 3:15 pm Breakout Sessions 3

A: Binge Eating Disorder** Sheraton Ballroom

Allan S. Kaplan, Faculty of Medicine, University of Toronto; Campbell Family Mental Health Research Institute; Center for Addiction and Mental Health

B: Child and Adolescent Mental Health McKnight East

Tina Nicholson, Calgary Foothills Primary Care Network

In this presentation, participants will discuss the extent to which the current levels of co-extant childhood mental health disorders such as ADHD, anxiety and depression can be addressed by well-informed and motivated family practitioners.


• Explain how CanReach may help to enable more effective management of child and adolescent mental health concerns within family practice • More easily recognize and be aware of child mental health problems such as ADHD, anxiety and depression within the scope of family medicine • Describe key features of the screening and assessment tools relevant to FPs


C: Recognition and Management of Depression and Alberta North Anxiety in the Perinatal Period Lisa Gagnon, Department of Psychiatry, University of Calgary


• Review the impact of maternal mental health problems for a developing fetus and infant • Discuss the risk factors for anxiety disorders and major depression in pregnancy and postpartum • Recognize the treatment options for anxiety and depressive symptoms in pregnancy and lactation

D: Polypharmacy in the Complex Psychiatric Patient* Alberta South

Lauren W. Zanussi, Department of Psychiatry, University of Calgary

3:15 – 3:45 pm Nutrition Break

3:45 – 4:45 pm Breakout Sessions 4 – Afternoon Sessions Repeat

A: Binge Eating Disorder** Sheraton Ballroom

Allan S. Kaplan, Faculty of Medicine, University of Toronto; Campbell Family Mental Health Research Institut; Center for Addiction and Mental Health

B: Child and Adolescent Mental Health McKnight East

Tina Nicholson, Calgary Foothills Primary Care Network

C: Recognition and Management of Depression and Alberta North

Anxiety in the Perinatal Period Lisa Gagnon, Department of Psychiatry, University of Calgary

D: Polypharmacy in the Complex Psychiatric Patient* Alberta South

Lauren W. Zanussi, Department of Psychiatry, University of Calgary

4:45 – 5:00 pm Evaluations and Close


Plenary Speakers

Allan S. KaplanDr. Allan S Kaplan MSc MD FRCPC is currently Vice Dean for Graduate and Life Science Education and Professor of Psychiatry in the Faculty of Medicine at the University of Toronto. He was previously Director of the Institute of Medical Science. He is also Senior Scientist, Campbell Family Mental Health Research Institute at the Center for Addiction and Mental Health. His research over the past 30 years has focused on innovative treatment approaches for eating disorders and on the genetics of anorexia and bulimia nervosa. He has published over 150 peer reviewed journal articles, two books, 50 book chap-ters and over 250 abstracts. He was the Head of the Toronto General Eating Disorder Program from 1994-2006, and the inaugural Chair-holder of the Loretta Anne Rogers Chair in Eating Disorders at the University Health Network, the first endowed Chair in Eating Disorders in the world. He was President of the Academy for Eating Disorders from 2001-2002, and President of the International Eating Disorder Research Society from 2005-2006. He has been a continuously funded peer reviewed investigator since 1992, and has received federal grant support from the National Institute of Mental Health in the USA and the Canadian Institutes of Health Research in Canada.

David TanoDr. David Tano MD FRCPC is currently working as the Section Chief for Outpatient Mental Health Services for the Department of Psychiatry, Calgary Zone, Alberta Health Services and as a forensic psychiatrist at the Southern Alberta Forensic Psychiatry Centre. He is also working as the consulting psychiatrist for the Communi-ty Extension Team, the Provincial Courts of Alberta, the Police Community Treatment Order Team and the Police and Crisis Team. He recently left the Peter Lougheed Hospital after working there for 11 years as an inpatient psychiatrist. For 6 years he worked as the Clinical Medi-cal Director of a general inpatient psychiatric unit and also consulted for 8 years to the federal halfway houses and federal institutions for Corrections Services Canada. He has been teaching residents and medical students for over 10 years and is currently a Royal College Examiner for the specialty of Psychiatry. He received his Bachelor of Science Degree from the University of Calgary and his Doctor of Medicine at the University of Alberta.


Sponsors

Silver

Gold

SOUTH CALGARY - Shared Care · Janssen Inc., Purdue Pharma, and Shire Canada. • Allan S. Kaplan has participated in advisory boards for Shire Canada. • Margaret Oakander has participated

Documents